{"id":"W3000047582","doi":"10.1016/s0923-7534(20)34342-8","title":"Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer: Phase III, Randomized, Double-Blind, Placebo-Controlled Mission Trial","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Sorafenib; Clinical endpoint; Internal medicine; Placebo; Discontinuation; Lung cancer; Randomized controlled trial; Progression-free survival; Oncology; Surgery; Chemotherapy; Gastroenterology; Pathology; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001459282,0.002750985,0.005523612,0.0005351515,0.000551906,0.001289048,0.001089859,0.002264764,0.006454958],"category_scores_gemma":[0.001333156,0.0009736032,0.002263907,0.0005312655,0.001457881,0.001585259,0.0004147083,0.003349405,0.00171744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006961189,"about_ca_system_score_gemma":0.001219262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007356461,"about_ca_topic_score_gemma":0.001788974,"domain_scores_codex":[0.9994521,0.000225632,0.00003666158,0.0001433537,0.00004185826,0.0001003947],"domain_scores_gemma":[0.9993169,0.0001544518,0.000151227,0.00005811096,0.00005446056,0.0002649337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9827752,0.003964582,0.0002741386,0.0006424855,0.0008228187,0.00003205682,0.00003493541,0.0002715641,0.002559352,0.00007687201,0.0006854103,0.007860633],"study_design_scores_gemma":[0.9638099,0.03454361,0.0005677387,0.00001954419,0.0002396001,0.00002061347,0.0000138128,0.0002384449,0.0001994976,0.00008169776,0.0002546289,0.00001103901],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811715,0.007211566,0.00130932,0.001027904,0.001249683,0.004143837,0.001344551,0.0002967411,0.002244968],"genre_scores_gemma":[0.9828487,0.004277244,0.001847237,0.001266474,0.0006197208,0.0036934,0.001314017,0.0000453639,0.004087904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006454958,"threshold_uncertainty_score":0.02159393,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04848366754662953,"score_gpt":0.4256324827201047,"score_spread":0.3771488151734752,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}